This book chapter advances SDGs 3 and 17 by reviewing the neurochemical aspects of Alzheimer’s type of Dementia.

United Nations University, New York, March 2019. 

Focussing on SDGs 8 (Decent Work and Economic Growth), 16 (Peace, Justice and Strong Institutions) and 17 (Partnerships for the Goals), Dr Alison Gardner, head of the Rights Lab’s Governance Programme, discusses the Slavery-Free Communities Programme’s work, highlighting promising practices in the context of Nottingham and the UK.
Despite the great potential of mobile data to support the delivery of the sustainable development agenda across sub-Saharan Africa, access to the data remains a great challenge due to real or perceived barriers. In order to address gaps in timely data that provide information on the SDGs, a multistakeholder workshop was held in Nairobi, Kenya, in February 2019, contributing to SDGs 9 and 17.
In this short video, former UN Secretary-General, Ban Ki-moon, responds to two questions about the importance of data and partnerships in advancing the SDGs.
Image of Marcia Balisciano
During the World Economic Forum in Davos, Márcia Balisciano, Corporate Responsibility Director at RELX Group, spoke about how women are advancing the 17 SDGs in a panel empowering women to advance the goals.
Elsevier,

Biomarkers in Toxicology, Second Edition, 2019, Pages 885-894

This chapter advances the UN SDG goal 3 and 17 by discussing the etiology, disease mechanisms, and biomarkers of Alzheimer's disease.
This book chapter advances SDGs 3 and 17 by focusing primarily on the recent developments in Alzheimer's Disease diagnosis and their merits and demerits, including development of blood and cerebrospinal fluid–based biomarkers, imaging tools such as MRI, fMRI, and PET, proteomics, etc.
Elsevier,

Emerging and Reemerging Viral Pathogens, Volume 1: Fundamental and Basic Virology Aspects of Human, Animal and Plant Pathogens, 2020, Pages 53-68

The current availability of state-of-the-art genomic technologies such as pan-microbial microarrays and NGS provides an unprecedented opportunity to “cast a wide net” and surveys the full breadth of as-yet undiscovered pathogens in nature that pose significant threats to human health.
Advancing goal 17, this report seeks to inspire and guide companies, governments, cities and others involved in the implementation of Agenda 2030 to tap into the private capital markets and benefit from cheaper and more reliable capital to support the implementation of their SDG strategies. It introduces a roadmap for mainstream SDG bonds and corporate SDG finance to tap into the largest assets classes and respond to the specific financing challenges in emerging markets.
Investors, governments, and other stakeholders are increasingly demanding that companies demonstrate sustainable strategies aligned with the SDGs. A credible SDG strategy allows a company to clearly communicate its impact, facilitates easier access to the growing market for SDG financing, and connects investors with a pipeline of potential opportunities to address the SDG investment gap. This guide seeks to support companies looking to integrate the SDGs into their financial strategy and business model, contributing to SDGs 8, 12 and 17.

Pages